Market Capitalization (Millions $) |
168 |
Shares
Outstanding (Millions) |
28 |
Employees |
- |
Revenues (TTM) (Millions $) |
9 |
Net Income (TTM) (Millions $) |
-105 |
Cash Flow (TTM) (Millions $) |
-59 |
Capital Exp. (TTM) (Millions $) |
1 |
Syros Pharmaceuticals Inc
Syros Pharmaceuticals Inc is a biopharmaceutical company focusing on developing gene control therapies for patients suffering from cancer and other diseases. They aim to target the underlying causes of these diseases by understanding the regulatory components of the genome and utilizing their proprietary gene control platform. Syros uses deep insights into genomic regulatory networks to identify and target specific genes that play a crucial role in controlling disease. Their goal is to pioneer a new wave of precision medicines that can effectively treat previously intractable diseases.
Company Address: 35 CambridgePark Drive Cambridge 2140 MA
Company Phone Number: 744-1340 Stock Exchange / Ticker: NASDAQ SYRS
|